234 related articles for article (PubMed ID: 26206776)
1. 4-IPP, a selective MIF inhibitor, causes mitotic catastrophe in thyroid carcinomas.
Varinelli L; Caccia D; Volpi CC; Caccia C; De Bortoli M; Taverna E; Gualeni AV; Leoni V; Gloghini A; Manenti G; Bongarzone I
Endocr Relat Cancer; 2015 Oct; 22(5):759-75. PubMed ID: 26206776
[TBL] [Abstract][Full Text] [Related]
2. CD74 expression and its therapeutic potential in thyroid carcinoma.
Cheng SP; Liu CL; Chen MJ; Chien MN; Leung CH; Lin CH; Hsu YC; Lee JJ
Endocr Relat Cancer; 2015 Apr; 22(2):179-90. PubMed ID: 25600560
[TBL] [Abstract][Full Text] [Related]
3. LPS-mediated cell surface expression of CD74 promotes the proliferation of B cells in response to MIF.
Klasen C; Ziehm T; Huber M; Asare Y; Kapurniotu A; Shachar I; Bernhagen J; El Bounkari O
Cell Signal; 2018 Jun; 46():32-42. PubMed ID: 29476963
[TBL] [Abstract][Full Text] [Related]
4. Macrophage migration inhibitory factor-CD74 interaction regulates the expression of programmed cell death ligand 1 in melanoma cells.
Imaoka M; Tanese K; Masugi Y; Hayashi M; Sakamoto M
Cancer Sci; 2019 Jul; 110(7):2273-2283. PubMed ID: 31069878
[TBL] [Abstract][Full Text] [Related]
5. CD74 and macrophage migration inhibitory factor as therapeutic targets in gastric cancer.
Zheng YX; Yang M; Rong TT; Yuan XL; Ma YH; Wang ZH; Shen LS; Cui L
World J Gastroenterol; 2012 May; 18(18):2253-61. PubMed ID: 22611320
[TBL] [Abstract][Full Text] [Related]
6. Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells.
Baron N; Deuster O; Noelker C; Stüer C; Strik H; Schaller C; Dodel R; Meyer B; Bacher M
J Neurosci Res; 2011 May; 89(5):711-7. PubMed ID: 21360573
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological inhibition of macrophage migration inhibitory factor interferes with the proliferation and invasiveness of squamous carcinoma cells.
Kindt N; Laurent G; Nonclercq D; Journé F; Ghanem G; Duvillier H; Gabius HJ; Lechien J; Saussez S
Int J Oncol; 2013 Jul; 43(1):185-93. PubMed ID: 23677331
[TBL] [Abstract][Full Text] [Related]
8. MIF/CD74 axis is a target for novel therapies in colon carcinomatosis.
Bozzi F; Mogavero A; Varinelli L; Belfiore A; Manenti G; Caccia C; Volpi CC; Beznoussenko GV; Milione M; Leoni V; Gloghini A; Mironov AA; Leo E; Pilotti S; Pierotti MA; Bongarzone I; Gariboldi M
J Exp Clin Cancer Res; 2017 Jan; 36(1):16. PubMed ID: 28114961
[TBL] [Abstract][Full Text] [Related]
9. Single-cell RNA-seq reveals MIF-(CD74 + CXCR4) dependent inhibition of macrophages in metastatic papillary thyroid carcinoma.
Chen W; Yu X; Li H; Yuan S; Fu Y; Hu H; Liu F; Zhang Y; Zhong S
Oral Oncol; 2024 Jan; 148():106654. PubMed ID: 38061122
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells.
Meyer-Siegler KL; Iczkowski KA; Leng L; Bucala R; Vera PL
J Immunol; 2006 Dec; 177(12):8730-9. PubMed ID: 17142775
[TBL] [Abstract][Full Text] [Related]
11. Endothelial CD74 mediates macrophage migration inhibitory factor protection in hyperoxic lung injury.
Sauler M; Zhang Y; Min JN; Leng L; Shan P; Roberts S; Jorgensen WL; Bucala R; Lee PJ
FASEB J; 2015 May; 29(5):1940-9. PubMed ID: 25609432
[TBL] [Abstract][Full Text] [Related]
12. Macrophage migration inhibitory factor confers resistance to senescence through CD74-dependent AMPK-FOXO3a signaling in mesenchymal stem cells.
Xia W; Zhang F; Xie C; Jiang M; Hou M
Stem Cell Res Ther; 2015 Apr; 6(1):82. PubMed ID: 25896286
[TBL] [Abstract][Full Text] [Related]
13. Role of MIF/CD74 signaling pathway in the development of pleural mesothelioma.
D'Amato-Brito C; Cipriano D; Colin DJ; Germain S; Seimbille Y; Robert JH; Triponez F; Serre-Beinier V
Oncotarget; 2016 Mar; 7(10):11512-25. PubMed ID: 26883190
[TBL] [Abstract][Full Text] [Related]
14. Macrophage migration inhibitory factor (MIF) promotes cell survival and proliferation of neural stem/progenitor cells.
Ohta S; Misawa A; Fukaya R; Inoue S; Kanemura Y; Okano H; Kawakami Y; Toda M
J Cell Sci; 2012 Jul; 125(Pt 13):3210-20. PubMed ID: 22454509
[TBL] [Abstract][Full Text] [Related]
15. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
Kang Y; Zhang Y; Sun Y
Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
[TBL] [Abstract][Full Text] [Related]
16. Macrophage migration inhibitory factor (MIF) is rendered enzymatically inactive by myeloperoxidase-derived oxidants but retains its immunomodulatory function.
Dickerhof N; Schindler L; Bernhagen J; Kettle AJ; Hampton MB
Free Radic Biol Med; 2015 Dec; 89():498-511. PubMed ID: 26453918
[TBL] [Abstract][Full Text] [Related]
17. Destabilization of macrophage migration inhibitory factor by 4-IPP reduces NF-κB/P-TEFb complex-mediated c-Myb transcription to suppress osteosarcoma tumourigenesis.
Zheng L; Feng Z; Tao S; Gao J; Lin Y; Wei X; Zheng B; Huang B; Zheng Z; Zhang X; Liu J; Shan Z; Chen Y; Chen J; Zhao F
Clin Transl Med; 2022 Jan; 12(1):e652. PubMed ID: 35060345
[TBL] [Abstract][Full Text] [Related]
18. MIF, CD74 and other partners in kidney disease: tales of a promiscuous couple.
Sanchez-Niño MD; Sanz AB; Ruiz-Andres O; Poveda J; Izquierdo MC; Selgas R; Egido J; Ortiz A
Cytokine Growth Factor Rev; 2013 Feb; 24(1):23-40. PubMed ID: 22959722
[TBL] [Abstract][Full Text] [Related]
19. Oral squamous carcinoma cells promote macrophage polarization in an MIF-dependent manner.
Barbosa de Souza Rizzo M; Brasilino de Carvalho M; Kim EJ; Rendon BE; Noe JT; Darlene Wise A; Mitchell RA
QJM; 2018 Nov; 111(11):769-778. PubMed ID: 30016493
[TBL] [Abstract][Full Text] [Related]
20. Tumor-derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation.
Dumitru CA; Gholaman H; Trellakis S; Bruderek K; Dominas N; Gu X; Bankfalvi A; Whiteside TL; Lang S; Brandau S
Int J Cancer; 2011 Aug; 129(4):859-69. PubMed ID: 21328346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]